Table 2.
Disease-free survival at 5 years, according to IASLC/ATS/ERS adenocarcinoma histological subtypes (adapted from [60]).
| IASLC/ATS/ERS Classification Subtypes | Number (%) | Disease Free Survival 5 Years |
|---|---|---|
| Low grade | ||
| In situ adenocarcinoma | 1 (0.2%) | 100% |
| Minimally invasive adenocarcinoma | 8 (1.2%) | 100% |
| Intermediate grade | ||
| Lepidic predominant | 29 (6%) | 90% |
| Acinar predominant | 232 (45%) | 84% |
| Papillary predominant | 143 (28%) | 83% |
| High grade | ||
| Micropapillary predominant | 12 (2%) | 67% |
| Solid predominant | 67 (13%) | 70% |
| Colloid predominant | 9(2%) | 71% |
| Invasive mucinous adenocarcinoma and invasive mixed (mucinous/non-mucinous) adenocarcinoma | 13 (3%) | 76% |